Challenge TB Final Report
The USAID-funded, KNCV-led Challenge TB (CTB) project operated from 2014 to 2019 in 24 countries and two regions. The overall purpose of CTB was to support countries with high burdens of tuberculosis (TB), multidrug-resistant TB (MDR-TB), and TB/HIV to achieve their National Strategic Plan goals, contribute to the US Government TB Strategic Targets (2015-2019), and make progress toward the post-2015 global goals. More than 10 million people were successfully treated for TB, and 275,000 patients received treatment for drug-resistant TB. MSH was a major partner in this global effort, leading the programs in Afghanistan, Bangladesh, and South Sudan, and making a major contribution to those in the Democratic Republic of Congo, Ethiopia, and Nigeria.